中國生物製藥有限公司 - 資產負債表 (Quarterly)

中國生物製藥有限公司
DE ˙ DB ˙ KYG8167W1380
€0.51 ↓ -0.00 (-0.45%)
2026-06-04
分享價格
資產負債表 (Quarterly)

中國生物製藥有限公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
12-31
2024
03-31
2024
06-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
現金 8,028 10,569 10,569 7,768 7,768 12,066 12,066 11,577 11,577 9,452 8,549 8,549 9,570 11,104 11,104 12,181 12,181
改變 (%) 31.64 0.00 -26.50 0.00 55.33 0.00 -4.05 0.00 -18.36 -9.55 0.00 11.93 16.04 0.00 9.69 0.00
流動資產 23,813 23,503 23,503 25,198 25,198 25,935 25,935 26,977 26,977 23,806 25,222 25,222 24,685 33,820 33,820 34,465 34,465
改變 (%) -1.30 0.00 7.21 0.00 2.93 0.00 4.02 0.00 -11.76 5.95 0.00 -2.13 37.01 0.00 1.91 0.00
資產 56,207 60,543 60,543 64,934 64,934 64,064 64,064 65,641 65,641 63,605 66,704 66,704 65,408 74,894 74,894 76,010 76,010
改變 (%) 7.72 0.00 7.25 0.00 -1.34 0.00 2.46 0.00 -3.10 4.87 0.00 -1.94 14.50 0.00 1.49 0.00
負債 25,098 22,814 22,814 26,190 26,190 26,121 26,121 29,182 29,182 25,435 24,582 24,582 22,634 29,117 29,117 33,924 33,924
改變 (%) -9.10 0.00 14.80 0.00 -0.26 0.00 11.72 0.00 -12.84 -3.35 0.00 -7.92 28.64 0.00 16.51 0.00
公平 31,109 37,729 37,729 38,745 38,745 37,944 37,944 36,459 36,459 38,170 42,122 42,122 42,774 45,778 45,778 42,086 42,086
改變 (%) 21.28 0.00 2.69 0.00 -2.07 0.00 -3.91 0.00 4.69 10.35 0.00 1.55 7.02 0.00 -8.06 0.00
負債和股本 56,207 60,543 60,543 64,934 64,934 64,064 64,064 65,641 65,641 63,605 66,704 66,704 65,408 74,894 74,894 76,010 76,010
改變 (%) 7.72 0.00 7.25 0.00 -1.34 0.00 2.46 0.00 -3.10 4.87 0.00 -1.94 14.50 0.00 1.49 0.00

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
HK:1177 HK$4.77
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista